Skip to content

Register and DNA Bank of Adult Extra-hospital Sudden Death (Protocol FASTER)

Register and DNA Bank of Adult Extra-hospital Sudden Death

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01321918
Enrollment
2000
Registered
2011-03-24
Start date
2007-06-30
Completion date
2010-11-30
Last updated
2011-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extra-hospital Sudden Death

Brief summary

The main objective of this study is the formation of a DNA bank to realise a case-control genetic study designed to identify sequence variations in DNA that predispose to sudden cardiac death in adults. The secondary objective of this study is the creation of a register for epidemiological surveillance of adult extra-hospital sudden death.

Interventions

OTHERCase Controls

A blood sample of 10 ml (2 x 5 ml) on two EDTA tubes will be realised on a route of vascular development place in the context of medical practice.Clinical data will be indicated in the CRF and the computerized database. In the event an eligible patient has not been included during his support by an emergency ambulance service but, after successful resuscitation, he has been hospitalised in a cardiology department, its inclusion may be realised during the hospitalization by a physician investigator of the study. A blood sample of 10 ml of 2 EDTA tubes will be realised on a route of vascular development in the context of routine care.

A blood sample of 10 ml (2 x 5 ml) on two EDTA tubes will be realised and clinical data will be indicated in the CRF and the computerized database.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: * Inclusion criteria for register : * Adults ≥ 18 years of age. * Persons who experienced sudden death defined as follows :cardiovascular arrest of non traumatic origin that occurred unexpectedly within an hour after the start of any prodromes. * Patients not hospitalized at the time of sudden death. * Inclusion criteria for DNA bank : * Case subjects : * Adults ≥ 18 years of age. * Persons who experienced sudden death defined as follows :cardiovascular arrest of non traumatic origin that occurred unexpectedly within an hour after the start of any prodromes. * Patients not hospitalized at the time of sudden death. * Patients supported clinically by an emergency ambulance service. * Control subjects : * Adults ≥ 18 years of age. * Adults hospitalized in an cardiac intensive care unit.

Exclusion criteria

: *

Design outcomes

Primary

MeasureTime frameDescription
Identification of variants in DNAThe primary endpoint is the identification of variants (polymorphisms and / or mutations) in DNA significantly associated with risk of extra-hospital sudden death in adults. Study populations are : (i) the entire population of case subjects included in the DNA bank (ii) two subpopulations at high risk of sudden death : patients with a history of myocardial infarction and patients with LVEF \< 30 %. The variable analyzed is the nucleotide sequence of DNA in populations of case and control subjects.

Secondary

MeasureTime frameDescription
Annual incidence of extra-hospital sudden death in adultsThe annual incidence of extra-hospital sudden death in adults. The variable analyzed is the number of incident cases per year of extra-hospital sudden death in adults.
Annual mortality related to extra-hospital sudden death in adultsThe annual mortality related to extra-hospital sudden death in adults. The variable analyzed is the number of annual deaths due to sudden death in adults.
Characterization of victims of extra-hospital sudden death in adultsThe characterization of victims of extra-hospital sudden death in adults, their medical care in emergency and their future from D0 to D28. Variables analyzed are clinical data are collected in case report forms.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026